Sartorius Stedim Biotech S.A. (SRTOY)

Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	707.6	678.9	116.6	107.1	223.6	59.76
Short-Term Investments	-	9.9	9.5	24.8	12.7	9.84
Cash & Short-Term Investments	707.6	688.8	126.1	131.9	236.3	69.61
Cash Growth	1.80%	446.23%	-4.40%	-44.18%	239.49%	90.47%
Accounts Receivable	267	265.9	293.7	404.6	356	256.89
Other Receivables	29.4	33.8	39.8	14	14.7	6.06
Receivables	296.4	300.6	334.4	419.7	371.7	263.96
Inventory	683.5	684.9	882.4	1,025	783	471.03
Other Current Assets	92.5	66.7	72.2	94.8	64.6	69.34
Total Current Assets	1,780	1,741	1,415	1,671	1,456	873.95
Property, Plant & Equipment	1,927	1,163	1,036	808	640.2	518.6
Long-Term Investments	23.7	24	40.8	24.9	14.8	-
Goodwill	2,901	2,908	2,885	1,136	820.7	725.15
Other Intangible Assets	1,599	1,361	1,465	712.1	563.3	473.83
Long-Term Deferred Tax Assets	67.3	63.2	60	61.6	46.5	27.48
Long-Term Deferred Charges	-	269	227.8	164.2	120.9	98.05
Other Long-Term Assets	4.8	727.6	601	487	289.1	139.68
Total Assets	8,304	8,256	7,730	5,065	3,951	2,857
Accounts Payable	317	310	258.5	251.5	251.4	174.73
Accrued Expenses	84.8	88.2	62.3	74.1	97.2	59.9
Current Portion of Long-Term Debt	69	39.5	57.7	4.5	25.5	13.11
Current Portion of Leases	21.5	25	21.4	19.5	14.9	10.88
Current Income Taxes Payable	87	123.2	189.4	209.6	165	71.52
Current Unearned Revenue	206	216.1	238.6	271	259.6	156.76
Other Current Liabilities	179.4	136.8	109.4	205.7	223.5	80.94
Total Current Liabilities	964.7	938.8	937.3	1,036	1,037	567.84
Long-Term Debt	2,684	2,684	3,510	1,021	521.1	515.66
Long-Term Leases	158.7	120.6	93.1	91.1	64	47.46
Long-Term Deferred Tax Liabilities	358.6	358.2	389.4	178.3	125.8	85.08
Other Long-Term Liabilities	95.5	91.3	92.2	189.7	423	130.15
Total Liabilities	4,296	4,233	5,056	2,551	2,218	1,396
Common Stock	19.5	19.5	18.4	18.4	18.4	18.44
Retained Earnings	2,529	2,496	2,391	2,179	1,397	1,209
Comprehensive Income & Other	1,424	1,471	229	251.9	240.2	210.42
Total Common Equity	3,972	3,987	2,639	2,449	1,656	1,438
Minority Interest	35.7	37.2	35.3	64.9	77.4	22.88
Shareholders' Equity	4,008	4,024	2,674	2,514	1,733	1,461
Total Liabilities & Equity	8,304	8,256	7,730	5,065	3,951	2,857
Total Debt	2,933	2,870	3,682	1,136	625.5	587.11
Net Cash (Debt)	-2,225	-2,181	-3,556	-1,004	-389.2	-517.5
Net Cash Per Share	-22.99	-22.53	-38.58	-10.89	-4.22	-5.61
Filing Date Shares Outstanding	97.27	97.3	92.16	92.16	92.18	92.18
Total Common Shares Outstanding	97.27	97.3	92.16	92.16	92.18	92.18
Working Capital	815.3	802.2	477.8	635.3	418.5	306.11
Book Value Per Share	40.84	40.97	28.63	26.58	17.96	15.60
Tangible Book Value	-528.5	-282.4	-1,711	600.8	271.9	239.15
Tangible Book Value Per Share	-5.43	-2.90	-18.57	6.52	2.95	2.59
Land	-	803.1	707.8	509.1	426.2	351.65
Machinery	-	796.2	688.5	581.3	469.7	384.92
Order Backlog	-	1,482	1,495	1,844	1,915	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.